Cargando…

Pharmaco-Immunomodulatory Therapy in COVID-19

The severe acute respiratory syndrome coronavirus 2 associated coronavirus disease 2019 (COVID-19) illness is a syndrome of viral replication in concert with a host inflammatory response. The cytokine storm and viral evasion of cellular immune responses may play an equally important role in the path...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rizk, John G., Kalantar-Zadeh, Kamyar, Mehra, Mandeep R., Lavie, Carl J., Rizk, Youssef, Forthal, Donald N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Leading Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372203/ https://www.ncbi.nlm.nih.gov/pubmed/32696108 http://dx.doi.org/10.1007/s40265-020-01367-z

Ejemplares similares

Authors’ Reply to Vrachatis et al. “Pharmaco-Immunomodulatory Therapy in COVID-19”
por: Rizk, John G., et al.
Publicado: (2020)

Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic.
por: Rizk, John G., et al.
Publicado: (2021)

Comment on: “Pharmaco-Immunomodulatory Therapy in COVID-19”
por: Vrachatis, Dimitrios A., et al.
Publicado: (2020)

Nutritional status and eating habits of people who use drugs and/or are undergoing treatment for recovery: a narrative review
por: Mahboub, Nadine, et al.
Publicado: (2020)

Proposed Pathogenesis, Characteristics, and Management of COVID-19 mRNA Vaccine-Related Myopericarditis
por: Hajra, Adrija, et al.
Publicado: (2021)

Prevention and Treatment of Monkeypox
por: Rizk, John G., et al.
Publicado: (2022)

COVID-19 and the paediatric acute abdomen—the emerging dilemma of PIMS-TS
por: Walker, Eleanor T., et al.
Publicado: (2022)

COVID‐19 and its effects on the digestive system and endoscopy practice
por: Aguila, Enrik John T., et al.
Publicado: (2020)

Current Overview on Hypercoagulability in COVID-19
por: Singhania, Namrata, et al.
Publicado: (2020)

One world, one pandemic, many guidelines: management of liver diseases during COVID-19
por: Bollipo, Steven, et al.
Publicado: (2020)

The Impact of the COVID-19 “Infodemic” on Drug-Utilization Behaviors: Implications for Pharmacovigilance
por: Tuccori, Marco, et al.
Publicado: (2020)

The Emergency Use Authorization of Pharmaceuticals: History and Utility During the COVID-19 Pandemic
por: Tran, Allan, et al.
Publicado: (2021)

The effects of COVID-19 pandemic on the provision of urgent surgery: a perspective from the USA
por: Cheeyandira, Abhiman
Publicado: (2020)

How the Global COVID-19 Pandemic Brought Drug and Vaccine Development into the Public Mainstream
por: Witek, Theodore J.
Publicado: (2021)

Overview of Current Drugs and Molecules in Development for Spinal Muscular Atrophy Therapy
por: Shorrock, Hannah K., et al.
Publicado: (2018)

Prioritisation and the initiation of HCC surveillance in CHB patients: lessons to learn from the COVID-19 crisis
por: Zeng, Georgia, et al.
Publicado: (2020)

Transformative therapy in hypophosphatasia
por: Bishop, Nick, et al.
Publicado: (2016)

COVID-19 and stroke—Understanding the relationship and adapting services. A global World Stroke Organisation perspective
por: Markus, Hugh S, et al.
Publicado: (2021)

ArrhythmoGenoPharmacoTherapy
por: Tosaki, Arpad
Publicado: (2020)

Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19: Rationale, Clinical Evidence and Risks
por: Crisafulli, Salvatore, et al.
Publicado: (2020)

“Learning by Design”: What Sports Coaches can Learn from Video Game Designs
por: Robertson, Sam, et al.
Publicado: (2021)

Recent Advances in Antiarrhythmic Drug Therapy
por: Saljic, Arnela, et al.
Publicado: (2023)

RNAi Therapy for HIV Infection: Principles and Practicalities
por: Bennasser, Yamina, et al.
Publicado: (2012)

Joining with the Conversation: Research as a Sustainable Practice in the Sport Sciences
por: Woods, Carl T., et al.
Publicado: (2022)

Pulmonary vasodilators: beyond the bounds of pulmonary arterial hypertension therapy in COVID-19
por: Franco, Veronica, et al.
Publicado: (2020)

Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) Working Party guidelines on IBD management during the COVID‐19 pandemic
por: Ling, Khoon Lin, et al.
Publicado: (2020)

The New Era of Drug Therapy for Obesity: The Evidence and the Expectations
por: Jones, Ben J., et al.
Publicado: (2015)

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
por: Bakota, Lidia, et al.
Publicado: (2016)

Clinical Impact of Checkpoint Inhibitors as Novel Cancer Therapies
por: Shih, Kent, et al.
Publicado: (2014)

Ramatroban as a Novel Immunotherapy for COVID-19
por: Gupta, Ajay, et al.
Publicado: (2020)

Use of Biologic Agents in Combination with Other Therapies for the Treatment of Psoriasis
por: Cather, Jennifer C., et al.
Publicado: (2014)

Severe Acute Respiratory Syndrome: Pertinent Clinical Characteristics and Therapy
por: File, Thomas M., et al.
Publicado: (2012)

Antisense Oligonucleotide Therapy: From Design to the Huntington Disease Clinic
por: Rook, Morgan E., et al.
Publicado: (2022)

Anti-Tumour Necrosis Factor Therapy for Paediatric Crohn’s Disease: Improved Benefits Through Treatment Optimisation, Deeper Understanding of Its Risks, and Reduced Costs due to Biosimilar Availability
por: Cozijnsen, M. A., et al.
Publicado: (2017)

Bruton’s Tyrosine Kinase Inhibition as an Emerging Therapy in Systemic Autoimmune Disease
por: Neys, Stefan F. H., et al.
Publicado: (2021)

Call for better response evaluation after neoadjuvant therapy in pancreatic cancer
por: Zaharia, Claudia, et al.
Publicado: (2023)

COVID‐19: a major cause of cachexia and sarcopenia?
por: Morley, John E., et al.
Publicado: (2020)

Bone Sarcomas in Pediatrics: Progress in Our Understanding of Tumor Biology and Implications for Therapy
por: Rivera-Valentin, Rocio K., et al.
Publicado: (2015)

Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood–Brain Barrier
por: Stanimirovic, Danica B., et al.
Publicado: (2018)

The Role of Interleukin-8 and its Receptors in Inflammatory Lung Disease: Implications for Therapy
por: Pease, James E., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_av1mdahoegdv8s9tmtm2vhi8pn